What is the Ownership and Shareholding Structure of Unimed Drugs?
In 2017, Unimed Drugs had a promoter holding of 53.82% and a public holding of 46.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX